AACR-Bayer Innovation and Discovery Grants

Funding Agency:
American Association for Cancer Research

Bayer and the AACR are proud to announce the 2017 AACR-Bayer Innovation and Discovery Grants.

This grants partnership will promote the key tenets of the Bayer  Grants4Targets™ Initiative, providing new treatment options for cancers with high unmet medical need, encouraging innovation and translation of ideas from basic research into novel drugs, and fostering collaborations between excellent academic groups and the pharmaceutical industry. This program offers one-year grants of $25,000 to meritorious projects that examine important, and druggable*, novel targets and biomarkers.

It is anticipated that 10 grants will be funded.

Deadline: July 13, 2017

Agency Website

Eligibility Requirements

​In order to be eligible for this opportunity, applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical, or research institution within North America.

Investigators may submit only one application for an AACR-Bayer Innovation and Discovery Grant but may concurrently apply for other AACR grants.



Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

July 13, 2017